Long term efficacy, safety and immunogenicity of biosimilar infliximab after one year in a prospective nationwide cohort

Absztrakt
Leírás
Kulcsszavak
Forrás
Inflammatory Bowel Diseases. -23 : 11 (2017), p. 1908-1915. -Inflamm. Bowel Dis. - 1078-0998